Beyond Hormone Therapy for Prostate Cancer with PARP inhibitors

Cancer Cell

Volumn 19, Issue 5, 2011, Pages 573-574

  Sebastian de Bono, Johann ^a   Sandhu, Shahneen ^a   Attard, Gerhardt ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN; HYBRID PROTEIN; MK 4827; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLAPARIB; POLY(ADENOSINE DIPHOSPHATE RIBOSE); TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DRUG MECHANISM; ELECTRORETINOGRAM; GENE FUSION; GENE REARRANGEMENT; HORMONAL THERAPY; HUMAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY;

EID: 79955973590     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.05.003     Document Type: Short Survey

References (12)

1. Attard G., Cooper C.S., de Bono J.S. Cancer Cell 2009, 16:458-462.
2. Attard G., Swennenhuis J.F., Olmos D., Reid A.H.M., Vickers E., A'Hern R., Levink R., Coumans F., Moreira J., Riisnaes R., Oommen N.B., et al. Cancer Res. 2009, 69:2912-2918.
3. Brenner C.J., Ateeq B. Cancer Cell 2011, 19:664-678. this issue.
4. Dedes K.J., Wetterskog D., Mendes-Pereira A.M., Natrajan R., Lambros M.B., Geyer F.C., Vatcheva R., Savage K., Mackay A., Lord C.J., Ashworth A., Reis-Filho J.S. Sci. Transl. Med. 2010, 2. 53ra75.
5. Fong P.C., Boss D.S., Yap T.A., Tutt A., Wu P., Mergui-Roelvink M., Mortimer P., Swaisland H., Lau A., O'Connor M.J., et al. N. Engl. J. Med. 2009, 361:123-134.
6. Haffner M.C., Aryee M.J., Toubaji A., Esopi D.M., Albadine R., Gurel B., Isaacs W.B., Bova G.S., Liu W., Xu J., et al. Nat. Genet. 2010, 42:668-675.
7. Lin C., Yang L., Tanasa B., Hutt K., Ju B.-g., Ohgi K., Zhang J., Rose D.W., Fu X.-D., Glass C.K., Rosenfeld M.G. Cell 2009, 139:1069-1083.
8. Mendes-Pereira A.M., Martin S.A., Brough R., McCarthy A., Taylor J.R., Kim J.S., Waldman T., Lord C.J., Ashworth A. EMBO Mol. Med. 2009, 1(6-7):315-322.
9. Reid A.H.M., Attard G., Ambroisine L., Fisher G., Kovacs G., Brewer D., Clark J., Flohr P., Edwards S., Berney D.M., et al. Br. J. Cancer 2010, 102:678-684.
10. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.-W., Varambally S., Cao X., Tchinda J., Kuefer R., et al. Science 2005, 310:644-648.
11. Tomlins S.A., Laxman B., Varambally S., Cao X., Yu J., Helgeson B.E., Cao Q., Prensner J.R., Rubin M.A., Shah R.B., et al. NEO 2008, 10:177-188.
12. Yap T.A., Sandhu S.K., Carden C.P., de Bono J.S. CA Cancer J. Clin. 2011 Jan-Feb, 61(1):31-49.